Interferon α/β enhances the cytotoxic response of MEK inhibition in melanoma

Drugs that inhibit the MAPK pathway have therapeutic benefit in melanoma, but responses vary between patients, for reasons that are still largely unknown. Here we aim at explaining this variability using pre- and post-MEK inhibition transcriptional profiles in a panel of melanoma cell-lines. We foun...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Cell
Autores principales: Litvin, Oren, Schwartz, Sarit, Wan, Zhenmao, Schild, Tanya, Rocco, Mark, Oh, Nul Loren, Chen, Bo-Juen, Goddard, Noel, Pratilas, Christine, Pe’er, Dana
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4355234/
https://ncbi.nlm.nih.gov/pubmed/25684207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2014.12.030
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares